Adverum Biotechnologies Reports Recent Business Progress and Fourth Quarter 2019 Financial Results

Go back to Adverum Biotechnologies Reports Recent Business Progress and Fourth Quarter 2019 Financial Results

Adverum Biotechnologies (ADVM) Reports In-Line Q4 EPS

March 12, 2020 4:16 PM EDT

Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 EPS of ($0.29), in-line with the analyst estimate of ($0.29).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

... More